Cel-Sci
CVM
#9766
Rank
HK$0.40 B
Marketcap
HK$50.19
Share price
2.54%
Change (1 day)
-61.61%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -HK$0.2 Billion

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.21 Billion, an increase over its 2023 earnings that were of -HK$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.2 Billion-6.84%
2024 -HK$0.21 Billion-12.41%
2023 -HK$0.24 Billion-12.87%
2022 -HK$0.28 Billion-3.42%
2021 -HK$0.29 Billion13.44%
2020 -HK$0.25 Billion11.28%
2019 -HK$0.23 Billion179.81%
2018 -HK$79.41 Million-48.72%
2017 -HK$0.16 Billion-16.23%
2016 -HK$0.19 Billion-23.63%
2015 -HK$0.25 Billion-5.47%
2014 -HK$0.26 Billion198.49%
2013 -HK$85.79 Million
2010 -HK$0.11 Billion
2004 -HK$33.85 Million12.38%
2003 -HK$30.12 Million-16.59%
2002 -HK$36.11 Million-59.28%
2001 -HK$88.66 Million23.17%
2000 -HK$71.98 Million20.12%
1999 -HK$59.92 Million13.24%
1998 -HK$52.92 Million-20%
1997 -HK$66.15 Million46.55%
1996 -HK$45.14 Million34.88%
1995 -HK$33.47 Million2.38%
1994 -HK$32.69 Million68%
1993 -HK$19.46 Million78.57%
1992 -HK$10.9 Million180%
1991 -HK$3.9 Million25%
1990 -HK$3.12 Million-0%
1989 -HK$3.12 Million-71.43%
1988 -HK$10.9 Million-0%
1987 -HK$10.9 Million-46.15%
1986 -HK$20.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-HK$0.26 Billion 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$51.5 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.15 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-HK$1.08 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.78 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
HK$252.09 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.28 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$73.85 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA